An immunovirological study of central nervous system involvement during HIV-1 infection of chimpanzees

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue 1, 1996, Pages 12-17

  Grimaldi, L M E ^c   Murthy, K K ^a   Martine, G ^e   Furlan, R ^e   Franciotta, D ^b   Eichberg, J W ^a,d  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^e NONE

Author keywords

Acquired immunodeficiency syndrome; Central nervous system; Cerebrospinal fluid; Chimpanzees; Cytokines; Human immunodeficiency virus; Isoelectric focusing overlay; Oligoclonal bands; Virus isolation

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BLOOD BRAIN BARRIER; CHIMPANZEE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; VIRUS ENCEPHALITIS; VIRUS ISOLATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PAN (APE); PAN TROGLODYTES;

EID: 0029784663     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199609000-00002     Document Type: Article

References (34)

1. Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol 1989;77:225-36.
2. Diederich, N, Ackermann R, Jurgens R, Ortseifen M, Thun F, Schneider M, Vukadinovic I. Early involvement of the nervous system by human immune deficiency virus (HIV). A study of 79 patients. Eur Neurol 1988;28:93-103.
3. Chiodi F, Keys B, Albert J, et al. Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microblol 1992;30:1768-71.
4. Gray F, Hurtrel M, Hurtrel B. Early central nervous system changes in human immunodeficiency virus (HIV)-infection. Neuropathol Appl Neurobiol 1993;19:3-9.
5. Gendelman HE, Genis P, Jett M, Zhai QH, Nottet HS. An experimental model system for HIV-1-induced brain injury. Adv Neuroimmunol 1994;4:189-93.
6. Georgsson G. Neuropathologic aspects of lentiviral infections. Ann NY Acad Sci 1994;724:50-67.
7. Goudsmit J, Epstein LG, Paul DA, et al. Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees. Proc Natl Aca Sci USA 1987;84:3876-80.
8. Achim CL, Wang R, Miners DK, Wiley CA. Brain viral burden in HIV infection. J Neuropathol Exp Neurol 1994; 53:284-94.
9. Brew BJ, Paul MO, Nakajima G, Khan A, Gallardo H, Price RW. Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex. J Neurol Neurosurg Psychiatry 1994;57:784-9.
10. Biniek R, Gesemann H, Scheiermann M, Brockmeyer NH, Lehmann HJ. Human immunodeficiency virus antibodies in cerebrospinal fluid. J Neuroimmunol 1988;20:149-50.
11. Elovaara I, Nykyri E, Poutiainen E, Hokkanen L, Raininko R, Suni J. CSF follow-up in HIV-1 infection: intrathecal production of HIV-specific and unspecific IgG, and beta-2-microglobulin increase with duration of HIV-1 infection. Acta Neurol Scand 1993;87:388-96.
12. Lucey DR, VanCott TC, Loomis LD, et al. Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop). J Acquir Immune Defic Syndr 1993;6:994-1001.
13. Grimaldi LM, Roos RP, Devare SG, et al. Restricted heterogeneity of antibody to gp120 and p24in AIDS. J Immunol 1988;141:114-7.
14. Kaiser R, Dorries R, Luer W, et al. Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV. J Neurol 1989;236: 157-60.
15. Ciardi M, Sharief MK, Thompson EJ, et al. High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor. J Neurol Sci 1994;125:175-9.
16. Grimaldi LM, Martino GV, Franciotta DM, et al. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol 1991;29:21-5.
17. Merrill JE, Chen IS. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 1991; 5:2391-7.
18. Perrella O, Carrieri PB, Guarnaccia D, Soscia M. Cerebrospinal fluid cytokines in AIDS dementia complex. J Neurol 1992;239:87-8.
19. Fultz PN. Nonhuman primate models for AIDS. Clin Infect Dis 1993;17(Suppl 1):S230-5.
20. Gardner MB, Luciw PA. Animal models of AIDS. FASEBJ 1989;3:2593-606.
21. Alter HJ, Eichberg JW, Masur H, et al. Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science 1984;226:549-52.
22. Fultz PN, McClure HM, Daugherty H, et al. Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee. J Infect Dis 1986;154:896-900.
23. Fultz PN, Scrinivasan A, Greene CR, Butler D, Swenson RB, McClure HM. Superinfection of a chimpanzee with a second strain of immunodeficiency virus. J Virol 1987;61: 4026-9.
24. Nara PL, Robey WG, Arthur LO, et al. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol 1987;61:3173-80.
25. Eichberg JW, Zarling JM, Alter HJ, et al. T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpaanzees. J Virol 1987;61: 3804-8.
26. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977;37:385-90.
27. Link H, Tibbling G. Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand J Clin Lab Invest 1977;37:91-6.
28. Roos RP, Lichter M, Grimaldi LM, et al. Silver staining of cerebrospinal fluid IgG in isoelectric focusing gels. J Neurosci Methods 1983;8:375-80.
29. Ho WZ, Cherukuri R, Douglas SD. The macrophage and HIV-1. Immunol Ser 1994;60:569-87.
30. Gendelman HE, Lipton SA, Tardieu M, Bukrinsky MI, Nottet HS. The neuropathogenesis of HIV-1 infection. J Leukoc Biol 1994;56:389-98.
31. Schuitemaker H. Macrophage-tropic HIV-1 variants: initiators of infection and AIDS pathogenesis? J Leukoc Biol 1994;56:218-24.
32. Murthy KK, Jett CM, Eichberg JW. In vitro infection of macrophages from chimpanzees and other nonhuman primates with different isolates of HIV-1. 7th International Conference on AIDS, Florence, Italy 1991.
33. Eibl MM, Kupcu Z, Mannhalter JW, Eder G, Schaff Z. Dual tropism of HIV-1 IIIB for chimpanzee lymphocytes and monocytes. AIDS Res Hum Retroviruses 1992;8:69-75.
34. Gendelman HE, Ehrlich GD, Baca LM, et al. The inability of human immunodeficiency virus to infect chimpanzee monocytes can be overcome by serial viral passage in vivo. J Virol 1991;65:3853-63.